1. Are Clinical Ethics Consultants in Danger? An Analysis of the Potential Legal Liability of Individual Clinical Ethicists
2. 50. For a report noting limited FDA review of genetic tests thus far, see Holtzman, N.A. Watson, M.S. , eds., "Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing," (1997), available at (last visited April 26, 2004). The FDA has recently begun to assert greater jurisdiction in domains such as cloning and assisted reproduction. See, e.g., Merrill, R. , "Human Tissues and Reproductive Cloning: New Technologies Challenge FDA," Houston Journal of Health Law and Policy 3 (2002): 1-86
3. Merrill, R.A. Rose, B.J. , "FDA Regulation of Human Cloning: Usurpation or Statesmanship?"Harvard Journal of Law & Technology15 (2001): 85-148
4. President's Council on Bioethics, Reproduction and Responsibility, supra note 40, at 56-64. HIPAA restrictions on the use of genetic tests in group health insurance are found at Health Insurance Portability and Accountability Act (HIPAA), 29 U.S.C. §§ 1181-82 (2000).